multi function electron microscope Search Results


96
Thermo Fisher human gamma secretase
Human Gamma Secretase, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/Apoferritin/pmc06250425-326-30-94
Average 96 stars, based on 1 article reviews
human gamma secretase - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
NeuroNexus Technologies 4 channel silicon neural probe
4 Channel Silicon Neural Probe, supplied by NeuroNexus Technologies, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/Silicon+Neural+Probe+%2F+Silicon+Microelectrode+Array/pm32289725-70-17-25
Average 97 stars, based on 1 article reviews
4 channel silicon neural probe - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
TESCAN USA Inc vega gmu scanning electron microscope
Vega Gmu Scanning Electron Microscope, supplied by TESCAN USA Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/VEGA/pm30726243-155-7-6
Average 99 stars, based on 1 article reviews
vega gmu scanning electron microscope - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
Alomone Labs rabbit anti kir2 1 primary antibody
FIGURE 1 Location of C154Y and R312H mutations associated with Andersen-Tawil syndrome on <t>human</t> <t>Kir2.1</t> channel. (A) Cartoon representation of the cryo-EM structure of the human Kir2.1 channel (PDB ID 7ZDZ) where the location of the C154Y and R312H mutations is highlighted on the channel structure (red and green spheres, respectively). (B) Top view of the human Kir2.1 channel structure where the intra-subunit disulfide bond formed by C122 and C154 is highlighted in magenta sticks. The chains are indicated in parentheses. (C) Amino acid sequence alignment of the region comprising residues 121 to 155 (Kir2.1 numbering) between different Kir channels. The conserved C122 and C154 residues are indicated by black arrows (numbers 122 and 154). The alignment also highlights the selectivity filter of Kir channels (residues 142–146). The highly conserved amino acids are highlighted in purple. h_Kir: Human Kir, m_Kir: mouse Kir, c_Kir: chicken Kir. The amino acid sequence of the human Kir2.1 channel (h_Kir2.1) is highlighted in red.
Rabbit Anti Kir2 1 Primary Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/Anti-Kir2%2E1%2FKCNJ2+Antibody/10__1096_slash_fj__202401567r-66-7-13
Average 95 stars, based on 1 article reviews
rabbit anti kir2 1 primary antibody - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

97
Vazyme Biotech Co assays clonexpressmultis one step cloning kit vazyme c113 02 chromium next gem single cell 3ʹ gem
FIGURE 1 Location of C154Y and R312H mutations associated with Andersen-Tawil syndrome on <t>human</t> <t>Kir2.1</t> channel. (A) Cartoon representation of the cryo-EM structure of the human Kir2.1 channel (PDB ID 7ZDZ) where the location of the C154Y and R312H mutations is highlighted on the channel structure (red and green spheres, respectively). (B) Top view of the human Kir2.1 channel structure where the intra-subunit disulfide bond formed by C122 and C154 is highlighted in magenta sticks. The chains are indicated in parentheses. (C) Amino acid sequence alignment of the region comprising residues 121 to 155 (Kir2.1 numbering) between different Kir channels. The conserved C122 and C154 residues are indicated by black arrows (numbers 122 and 154). The alignment also highlights the selectivity filter of Kir channels (residues 142–146). The highly conserved amino acids are highlighted in purple. h_Kir: Human Kir, m_Kir: mouse Kir, c_Kir: chicken Kir. The amino acid sequence of the human Kir2.1 channel (h_Kir2.1) is highlighted in red.
Assays Clonexpressmultis One Step Cloning Kit Vazyme C113 02 Chromium Next Gem Single Cell 3ʹ Gem, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/ClonExpress+MultiS+One+Step+Cloning+Kit/pm40198221-826-173-179
Average 97 stars, based on 1 article reviews
assays clonexpressmultis one step cloning kit vazyme c113 02 chromium next gem single cell 3ʹ gem - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
JEOL jem f200 multi purpose transmission electron microscope tem
FIGURE 1 Location of C154Y and R312H mutations associated with Andersen-Tawil syndrome on <t>human</t> <t>Kir2.1</t> channel. (A) Cartoon representation of the cryo-EM structure of the human Kir2.1 channel (PDB ID 7ZDZ) where the location of the C154Y and R312H mutations is highlighted on the channel structure (red and green spheres, respectively). (B) Top view of the human Kir2.1 channel structure where the intra-subunit disulfide bond formed by C122 and C154 is highlighted in magenta sticks. The chains are indicated in parentheses. (C) Amino acid sequence alignment of the region comprising residues 121 to 155 (Kir2.1 numbering) between different Kir channels. The conserved C122 and C154 residues are indicated by black arrows (numbers 122 and 154). The alignment also highlights the selectivity filter of Kir channels (residues 142–146). The highly conserved amino acids are highlighted in purple. h_Kir: Human Kir, m_Kir: mouse Kir, c_Kir: chicken Kir. The amino acid sequence of the human Kir2.1 channel (h_Kir2.1) is highlighted in red.
Jem F200 Multi Purpose Transmission Electron Microscope Tem, supplied by JEOL, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/JEM-F200+Transmission+Electron+Microscope/10__20517_slash_cs__2024__13-71-11-10
Average 99 stars, based on 1 article reviews
jem f200 multi purpose transmission electron microscope tem - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
Electro-Optical Systems Inc multi-photon microscopy
FIGURE 1 Location of C154Y and R312H mutations associated with Andersen-Tawil syndrome on <t>human</t> <t>Kir2.1</t> channel. (A) Cartoon representation of the cryo-EM structure of the human Kir2.1 channel (PDB ID 7ZDZ) where the location of the C154Y and R312H mutations is highlighted on the channel structure (red and green spheres, respectively). (B) Top view of the human Kir2.1 channel structure where the intra-subunit disulfide bond formed by C122 and C154 is highlighted in magenta sticks. The chains are indicated in parentheses. (C) Amino acid sequence alignment of the region comprising residues 121 to 155 (Kir2.1 numbering) between different Kir channels. The conserved C122 and C154 residues are indicated by black arrows (numbers 122 and 154). The alignment also highlights the selectivity filter of Kir channels (residues 142–146). The highly conserved amino acids are highlighted in purple. h_Kir: Human Kir, m_Kir: mouse Kir, c_Kir: chicken Kir. The amino acid sequence of the human Kir2.1 channel (h_Kir2.1) is highlighted in red.
Multi Photon Microscopy, supplied by Electro-Optical Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/multi+photon+microscopy/10__1364_slash_oe__23__000484-495-6-24
Average 90 stars, based on 1 article reviews
multi-photon microscopy - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc cat no 2165s
Representation and validation of the AF4‐MALS‐FLD method . (A) Overview of the workflow used for identification of EV surface proteins. PE‐conjugated antibodies were incubated with the sample (e.g. pre‐purified EVs, cell culture supernatant, urine, or plasma) and loaded into the AF4 channel. (B) The light scatter elution profile (in relative scale) (black, full line), UV elution profile (black, dotted line) and the size determination ( R rms in nm) (red) obtained by the multi‐angle light scattering (MALS) detector is plotted against time for labelling of SK‐BR‐3‐derived EVs with PE‐conjugated anti‐CD81 antibody. (C) The fluorescent light detector (FLD) signal (in relative scale) for SK‐BR‐3‐derived EVs labelled with PE‐conjugated anti‐CD9, anti‐CD63 and anti‐CD81 is plotted against time. (D) Transmission electron microscopy (TEM) images of different fractions of the AF4‐MALS‐FLD elution profile are shown (scale bar = 200 nm).
Cat No 2165s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/HER2%2FErbB2+Rabbit+mAb/pmc12957769-71-71-74
Average 96 stars, based on 1 article reviews
cat no 2165s - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Philips Healthcare 100 electron microscope
Representation and validation of the AF4‐MALS‐FLD method . (A) Overview of the workflow used for identification of EV surface proteins. PE‐conjugated antibodies were incubated with the sample (e.g. pre‐purified EVs, cell culture supernatant, urine, or plasma) and loaded into the AF4 channel. (B) The light scatter elution profile (in relative scale) (black, full line), UV elution profile (black, dotted line) and the size determination ( R rms in nm) (red) obtained by the multi‐angle light scattering (MALS) detector is plotted against time for labelling of SK‐BR‐3‐derived EVs with PE‐conjugated anti‐CD81 antibody. (C) The fluorescent light detector (FLD) signal (in relative scale) for SK‐BR‐3‐derived EVs labelled with PE‐conjugated anti‐CD9, anti‐CD63 and anti‐CD81 is plotted against time. (D) Transmission electron microscopy (TEM) images of different fractions of the AF4‐MALS‐FLD elution profile are shown (scale bar = 200 nm).
100 Electron Microscope, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/100+electron+microscope/pmc01448651-89-28-23
Average 90 stars, based on 1 article reviews
100 electron microscope - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

97
Multi Sciences (Lianke) Biotech Co Ltd ag11718 human tgf β1 elisa kit multi sciences
Representation and validation of the AF4‐MALS‐FLD method . (A) Overview of the workflow used for identification of EV surface proteins. PE‐conjugated antibodies were incubated with the sample (e.g. pre‐purified EVs, cell culture supernatant, urine, or plasma) and loaded into the AF4 channel. (B) The light scatter elution profile (in relative scale) (black, full line), UV elution profile (black, dotted line) and the size determination ( R rms in nm) (red) obtained by the multi‐angle light scattering (MALS) detector is plotted against time for labelling of SK‐BR‐3‐derived EVs with PE‐conjugated anti‐CD81 antibody. (C) The fluorescent light detector (FLD) signal (in relative scale) for SK‐BR‐3‐derived EVs labelled with PE‐conjugated anti‐CD9, anti‐CD63 and anti‐CD81 is plotted against time. (D) Transmission electron microscopy (TEM) images of different fractions of the AF4‐MALS‐FLD elution profile are shown (scale bar = 200 nm).
Ag11718 Human Tgf β1 Elisa Kit Multi Sciences, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/Human%2FMouse%2FRat+TGF-%CE%B22+Standard/pm41863803-190-137-142
Average 97 stars, based on 1 article reviews
ag11718 human tgf β1 elisa kit multi sciences - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

95
JEOL field emission scanning electron microscopy
Representation and validation of the AF4‐MALS‐FLD method . (A) Overview of the workflow used for identification of EV surface proteins. PE‐conjugated antibodies were incubated with the sample (e.g. pre‐purified EVs, cell culture supernatant, urine, or plasma) and loaded into the AF4 channel. (B) The light scatter elution profile (in relative scale) (black, full line), UV elution profile (black, dotted line) and the size determination ( R rms in nm) (red) obtained by the multi‐angle light scattering (MALS) detector is plotted against time for labelling of SK‐BR‐3‐derived EVs with PE‐conjugated anti‐CD81 antibody. (C) The fluorescent light detector (FLD) signal (in relative scale) for SK‐BR‐3‐derived EVs labelled with PE‐conjugated anti‐CD9, anti‐CD63 and anti‐CD81 is plotted against time. (D) Transmission electron microscopy (TEM) images of different fractions of the AF4‐MALS‐FLD elution profile are shown (scale bar = 200 nm).
Field Emission Scanning Electron Microscopy, supplied by JEOL, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/JIB-4610F+FIB/10__1088_slash_1742___6596_slash_1428_slash_1_slash_012064-31-0-5
Average 95 stars, based on 1 article reviews
field emission scanning electron microscopy - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Eppendorf AG electronic multi dispenser pipette
Representation and validation of the AF4‐MALS‐FLD method . (A) Overview of the workflow used for identification of EV surface proteins. PE‐conjugated antibodies were incubated with the sample (e.g. pre‐purified EVs, cell culture supernatant, urine, or plasma) and loaded into the AF4 channel. (B) The light scatter elution profile (in relative scale) (black, full line), UV elution profile (black, dotted line) and the size determination ( R rms in nm) (red) obtained by the multi‐angle light scattering (MALS) detector is plotted against time for labelling of SK‐BR‐3‐derived EVs with PE‐conjugated anti‐CD81 antibody. (C) The fluorescent light detector (FLD) signal (in relative scale) for SK‐BR‐3‐derived EVs labelled with PE‐conjugated anti‐CD9, anti‐CD63 and anti‐CD81 is plotted against time. (D) Transmission electron microscopy (TEM) images of different fractions of the AF4‐MALS‐FLD elution profile are shown (scale bar = 200 nm).
Electronic Multi Dispenser Pipette, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+function+electron+microscope/Multipette+E3/pm36121202-150-214-219
Average 94 stars, based on 1 article reviews
electronic multi dispenser pipette - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


FIGURE 1 Location of C154Y and R312H mutations associated with Andersen-Tawil syndrome on human Kir2.1 channel. (A) Cartoon representation of the cryo-EM structure of the human Kir2.1 channel (PDB ID 7ZDZ) where the location of the C154Y and R312H mutations is highlighted on the channel structure (red and green spheres, respectively). (B) Top view of the human Kir2.1 channel structure where the intra-subunit disulfide bond formed by C122 and C154 is highlighted in magenta sticks. The chains are indicated in parentheses. (C) Amino acid sequence alignment of the region comprising residues 121 to 155 (Kir2.1 numbering) between different Kir channels. The conserved C122 and C154 residues are indicated by black arrows (numbers 122 and 154). The alignment also highlights the selectivity filter of Kir channels (residues 142–146). The highly conserved amino acids are highlighted in purple. h_Kir: Human Kir, m_Kir: mouse Kir, c_Kir: chicken Kir. The amino acid sequence of the human Kir2.1 channel (h_Kir2.1) is highlighted in red.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 1 Location of C154Y and R312H mutations associated with Andersen-Tawil syndrome on human Kir2.1 channel. (A) Cartoon representation of the cryo-EM structure of the human Kir2.1 channel (PDB ID 7ZDZ) where the location of the C154Y and R312H mutations is highlighted on the channel structure (red and green spheres, respectively). (B) Top view of the human Kir2.1 channel structure where the intra-subunit disulfide bond formed by C122 and C154 is highlighted in magenta sticks. The chains are indicated in parentheses. (C) Amino acid sequence alignment of the region comprising residues 121 to 155 (Kir2.1 numbering) between different Kir channels. The conserved C122 and C154 residues are indicated by black arrows (numbers 122 and 154). The alignment also highlights the selectivity filter of Kir channels (residues 142–146). The highly conserved amino acids are highlighted in purple. h_Kir: Human Kir, m_Kir: mouse Kir, c_Kir: chicken Kir. The amino acid sequence of the human Kir2.1 channel (h_Kir2.1) is highlighted in red.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: Cryo-Electron Microscopy, Sequencing

FIGURE 2 Functional expression of Kir2.1-WT and C154Y and R312H mutants in Xenopus laevis oocytes. Normalized current-voltage (I-V) relationships of the macroscopic currents of the Kir2.1 WT alone (injections of 50 and 25 ng of WT cDNA, blue and gray curves, respectively) and (A) R312H mutant alone (50 ng of R312H cDNA, green curve) or co-injected with WT cDNA (25 ng of WT cDNA +25 ng of R312H cDNA, cyan curve), and (B) C154Y mutant alone (50 ng of C154Y cDNA, red curve) or co-injected with WT cDNA (25 ng of WT cDNA +25 ng of C154Y cDNA, purple curve) compared to the control current of Kir2.1-WT (50 and 25 ng of cDNA, blue and gray curves) at −150 mV. Currents were elicited by 500 ms pulses from −150 mV to +30 mV in 10 mV increments from a holding potential of −60 mV. Values were measured at the end of each step pulse and represent mean ± SEM, n = 6–16 oocytes per group.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 2 Functional expression of Kir2.1-WT and C154Y and R312H mutants in Xenopus laevis oocytes. Normalized current-voltage (I-V) relationships of the macroscopic currents of the Kir2.1 WT alone (injections of 50 and 25 ng of WT cDNA, blue and gray curves, respectively) and (A) R312H mutant alone (50 ng of R312H cDNA, green curve) or co-injected with WT cDNA (25 ng of WT cDNA +25 ng of R312H cDNA, cyan curve), and (B) C154Y mutant alone (50 ng of C154Y cDNA, red curve) or co-injected with WT cDNA (25 ng of WT cDNA +25 ng of C154Y cDNA, purple curve) compared to the control current of Kir2.1-WT (50 and 25 ng of cDNA, blue and gray curves) at −150 mV. Currents were elicited by 500 ms pulses from −150 mV to +30 mV in 10 mV increments from a holding potential of −60 mV. Values were measured at the end of each step pulse and represent mean ± SEM, n = 6–16 oocytes per group.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: Functional Assay, Expressing, Mutagenesis, Injection, Control, Patch Clamp

FIGURE 3 Trafficking of the Kir2.1-WT and R312H and C154Y mutants to the membrane. (A) Immunofluorescence assays conducted in Xenopus laevis oocytes expressing Kir2.1-WT and mutants. Top row: visualization of Cy3-conjugated anti-rabbit secondary antibody (the primary antibody is a rabbit anti-Kir2.1) showing the location of Kir2.1-WT, Kir2.1-R312H, and Kir2.1-C154Y in the membrane (orange). Control (no cDNA Kir2.1 injected) is shown top left. Bottom row: same as top row but with the co-visualization of the co-injected green fluorescent protein (GFP), which is used to confirm the successful injection of cDNA into the oocytes. Oocytes were co-injected with 50 ng of cDNA encoding Kir2.1 (WT, R312H or C154Y) and 25 ng of cDNA encoding GFP or injected only with 25 ng of cDNA encoding GFP when indicated. Three independent experiments in three different oocytes batches were performed, and the results were consistently similar. One representative experiment is shown in the figure. (B) Cell surface protein biotinylation assays in Pichia pastoris cells. Left: SDS-PAGE of Kir2.1-WT and mutants purified after biotinylation and affinity chromatography revealed by Coomassie blue. The first lane refers to molecular weight markers. Middle: Western blot and Extravidin-HRP reaction highlighting the presence of protein Kir2.1-WT, and R312H and C154Y mutants at the membrane level. WT (−) is the result with the non-biotinylated membrane. Right: Western blot revealed by Anti-His antibody interaction with His-tagged Kir2.1.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 3 Trafficking of the Kir2.1-WT and R312H and C154Y mutants to the membrane. (A) Immunofluorescence assays conducted in Xenopus laevis oocytes expressing Kir2.1-WT and mutants. Top row: visualization of Cy3-conjugated anti-rabbit secondary antibody (the primary antibody is a rabbit anti-Kir2.1) showing the location of Kir2.1-WT, Kir2.1-R312H, and Kir2.1-C154Y in the membrane (orange). Control (no cDNA Kir2.1 injected) is shown top left. Bottom row: same as top row but with the co-visualization of the co-injected green fluorescent protein (GFP), which is used to confirm the successful injection of cDNA into the oocytes. Oocytes were co-injected with 50 ng of cDNA encoding Kir2.1 (WT, R312H or C154Y) and 25 ng of cDNA encoding GFP or injected only with 25 ng of cDNA encoding GFP when indicated. Three independent experiments in three different oocytes batches were performed, and the results were consistently similar. One representative experiment is shown in the figure. (B) Cell surface protein biotinylation assays in Pichia pastoris cells. Left: SDS-PAGE of Kir2.1-WT and mutants purified after biotinylation and affinity chromatography revealed by Coomassie blue. The first lane refers to molecular weight markers. Middle: Western blot and Extravidin-HRP reaction highlighting the presence of protein Kir2.1-WT, and R312H and C154Y mutants at the membrane level. WT (−) is the result with the non-biotinylated membrane. Right: Western blot revealed by Anti-His antibody interaction with His-tagged Kir2.1.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: Membrane, Immunofluorescence, Expressing, Control, Injection, Biotinylation, SDS Page, Purification, Affinity Chromatography, Molecular Weight, Western Blot

FIGURE 4 Biophysical characterization of the quaternary structure of Kir2.1-WT and R312H mutant. (A) SEC-MALLS-RI profile of Kir2.1-WT in 20 mM Tris–HCl pH 7.4, 150 mM KCl, 1 mM EDTA, 0.03% DDM (eluted on Superdex 10/300200 Increase); (B) Zoom on the peak corresponding to Kir2.1 tetramers; (C) SEC-MALLS-RI profile of Kir2.1-R312H in 20 mM Tris–HCl pH 7.4, 150 mM KCl, 1 mM EDTA, 0.03% DDM; (D) Zoom on the peak corresponding to Kir2.1-R312H tetramers. On each figure, the LS, UV, and RI profiles are shown in red, green, and blue, respectively. Molar mass distribution vs. elution volume of Kir2.1-DDM and Kir2.1-R312H-DDM complex were calculated using the module Protein Conjugate from the Astra V software (Wyatt Technology). A perfect alignment of the 3 signals (LS, UV, and RI) is observed at the center of the peaks. The total complex mass Kir2.1 molar mass, and DDM molar mass are shown as horizontal lines across the peak, depicting a monodisperse complex in DDM for both Kir2.1-WT and Kir2.1-R312H.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 4 Biophysical characterization of the quaternary structure of Kir2.1-WT and R312H mutant. (A) SEC-MALLS-RI profile of Kir2.1-WT in 20 mM Tris–HCl pH 7.4, 150 mM KCl, 1 mM EDTA, 0.03% DDM (eluted on Superdex 10/300200 Increase); (B) Zoom on the peak corresponding to Kir2.1 tetramers; (C) SEC-MALLS-RI profile of Kir2.1-R312H in 20 mM Tris–HCl pH 7.4, 150 mM KCl, 1 mM EDTA, 0.03% DDM; (D) Zoom on the peak corresponding to Kir2.1-R312H tetramers. On each figure, the LS, UV, and RI profiles are shown in red, green, and blue, respectively. Molar mass distribution vs. elution volume of Kir2.1-DDM and Kir2.1-R312H-DDM complex were calculated using the module Protein Conjugate from the Astra V software (Wyatt Technology). A perfect alignment of the 3 signals (LS, UV, and RI) is observed at the center of the peaks. The total complex mass Kir2.1 molar mass, and DDM molar mass are shown as horizontal lines across the peak, depicting a monodisperse complex in DDM for both Kir2.1-WT and Kir2.1-R312H.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: Mutagenesis, Software, Size-exclusion Chromatography, Multi-Angle Light Scattering

FIGURE 6 Surface plasmon resonance (SPR) sensorgram of the Kir2.1 WT (red) and Kir2.1-C154Y mutant (blue) (5844 RU level) immobilized onto a CM5 chip. Five sequential injections of PIP2 are shown, at 1.25–20 μM, and a flow of 5 μL/min. The sensorgram is expressed in response units (RU) relative to the time in seconds.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 6 Surface plasmon resonance (SPR) sensorgram of the Kir2.1 WT (red) and Kir2.1-C154Y mutant (blue) (5844 RU level) immobilized onto a CM5 chip. Five sequential injections of PIP2 are shown, at 1.25–20 μM, and a flow of 5 μL/min. The sensorgram is expressed in response units (RU) relative to the time in seconds.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: SPR Assay, Sensorgram, Mutagenesis

FIGURE 5 Cryo-EM structure of Kir2.1-R312H mutant. (A) Representative 2D-class averages. (B) Fourier-shell correlation (FSC) curves of the final map reconstruction provided by CryoSPARC v4.4 (C) Side and bottom views of the atomic structure of the Kir2.1-R312H mutant fitted in the cryo-map. The four chains (A to D) are highlighted as orange, red, blue and yellow cartoon, respectively. CTD, cytoplasmic domain; TMD, transmembrane domain.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 5 Cryo-EM structure of Kir2.1-R312H mutant. (A) Representative 2D-class averages. (B) Fourier-shell correlation (FSC) curves of the final map reconstruction provided by CryoSPARC v4.4 (C) Side and bottom views of the atomic structure of the Kir2.1-R312H mutant fitted in the cryo-map. The four chains (A to D) are highlighted as orange, red, blue and yellow cartoon, respectively. CTD, cytoplasmic domain; TMD, transmembrane domain.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: Cryo-Electron Microscopy, Mutagenesis

FIGURE 7 Analysis of the impact caused by the mutation C154Y on the Kir2.1 structure and on the root mean square fluctuation (rmsf) of the selectivity filter (region 142–146), the 147–153 loop, and the residue located at position 154. (A) Kir2.1WT (B) Kir2.1-C154Y Cartoon representation of the C122/C154 disulfide bond or C154Y and C122 are in red sticks. The extracellular loop (magenta) and the selectivity filter (cyan) are connected through the 146–153 loop (green). The residues T142, I143, and Y145 from the selectivity filter are highlighted in cyan sticks. (C) A representative WT chain (C154) from a representative replica of MD simulations performed with the Kir2.1-WT cryo-EM structure (PDB ID 7ZDZ). (D) A representative C154Y chain from a representative replica of MD simulations performed after incorporating the C154Y in the four subunits of the Kir2.1 tetramer. (E) A representative WT chain (C154) from a representative replica of MD simulations performed with structures containing the assembly of both WT and C154Y mutated subunits in the Kir2.1 tetramer (hybrid WT-C154Y models). In panels C, D, and E, the backbone a segment of the Kir2.1 structure containing part of the transmembrane domain (TMD) and the extracellular loop is shown in gray. The residues on which the rmsf was evaluated are showed in sticks and labeled according to their names and position. These residues are colored based on their rmsf values which are represented on the color scale ranging from 1.1 (blue, less flexible) to 2.4 (red, more flexible). Although a representative chain from a representative replica is shown in panels C, D, and E, these results were consistent across all chains from all replicas performed.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 7 Analysis of the impact caused by the mutation C154Y on the Kir2.1 structure and on the root mean square fluctuation (rmsf) of the selectivity filter (region 142–146), the 147–153 loop, and the residue located at position 154. (A) Kir2.1WT (B) Kir2.1-C154Y Cartoon representation of the C122/C154 disulfide bond or C154Y and C122 are in red sticks. The extracellular loop (magenta) and the selectivity filter (cyan) are connected through the 146–153 loop (green). The residues T142, I143, and Y145 from the selectivity filter are highlighted in cyan sticks. (C) A representative WT chain (C154) from a representative replica of MD simulations performed with the Kir2.1-WT cryo-EM structure (PDB ID 7ZDZ). (D) A representative C154Y chain from a representative replica of MD simulations performed after incorporating the C154Y in the four subunits of the Kir2.1 tetramer. (E) A representative WT chain (C154) from a representative replica of MD simulations performed with structures containing the assembly of both WT and C154Y mutated subunits in the Kir2.1 tetramer (hybrid WT-C154Y models). In panels C, D, and E, the backbone a segment of the Kir2.1 structure containing part of the transmembrane domain (TMD) and the extracellular loop is shown in gray. The residues on which the rmsf was evaluated are showed in sticks and labeled according to their names and position. These residues are colored based on their rmsf values which are represented on the color scale ranging from 1.1 (blue, less flexible) to 2.4 (red, more flexible). Although a representative chain from a representative replica is shown in panels C, D, and E, these results were consistent across all chains from all replicas performed.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: Analysis, Mutagenesis, Residue, Cryo-Electron Microscopy, Labeling

FIGURE 8 Dihedral angles analysis of the selectivity filter residues (T142, I143, and Y145) of the Kir2.1 channel. Dihedral angle frequency for the T142 (panel A), Y145 (panel B), and I143 (panel E) residues obtained along the 200 ns of MD simulations in triplicate of the Kir2.1 channel cryo-EM structure WT (four chains C154; left column) and after incorporating the C154Y mutation in the four subunits of the tetramer (Chains ABCDC154Y; right column). For residue T142 (panel A), the frequency of dihedral angles in the ranges of −40° to −30°, −20° to −10°, and 30° to 40° are highlighted in brown, cyan, and green, respectively. For residue Y145 (panel B), the frequency of dihedral angles in the ranges of −30° to −20°, −10° to 0°, and 30° to 40° are highlighted in brown, cyan, and green, respectively. Panels C and D show snapshots captured along the MD simulations to illustrate these dihedral angle ranges for the side chains (shown in sticks) of the residues T142 (panel C) and Y145 (panel D). The dihedral angle frequency analysis of residue I143 (panel E) is not highlighted because the impact of the C154Y mutation on it was inconclusive.

Journal: The FASEB Journal

Article Title: Biochemical, biophysical, and structural investigations of two mutants (C154Y and R312H) of the human Kir2.1 channel involved in the Andersen‐Tawil syndrome

doi: 10.1096/fj.202401567r

Figure Lengend Snippet: FIGURE 8 Dihedral angles analysis of the selectivity filter residues (T142, I143, and Y145) of the Kir2.1 channel. Dihedral angle frequency for the T142 (panel A), Y145 (panel B), and I143 (panel E) residues obtained along the 200 ns of MD simulations in triplicate of the Kir2.1 channel cryo-EM structure WT (four chains C154; left column) and after incorporating the C154Y mutation in the four subunits of the tetramer (Chains ABCDC154Y; right column). For residue T142 (panel A), the frequency of dihedral angles in the ranges of −40° to −30°, −20° to −10°, and 30° to 40° are highlighted in brown, cyan, and green, respectively. For residue Y145 (panel B), the frequency of dihedral angles in the ranges of −30° to −20°, −10° to 0°, and 30° to 40° are highlighted in brown, cyan, and green, respectively. Panels C and D show snapshots captured along the MD simulations to illustrate these dihedral angle ranges for the side chains (shown in sticks) of the residues T142 (panel C) and Y145 (panel D). The dihedral angle frequency analysis of residue I143 (panel E) is not highlighted because the impact of the C154Y mutation on it was inconclusive.

Article Snippet: For immunolabeling, oocytes were incubated with the Rabbit anti- Kir2.1 primary antibody (1:200, Alomone Labs) in 2% horse serum for 1 h 30 min at room temperature and washed two times with 2% horse serum for 5 min each.

Techniques: Analysis, Cryo-Electron Microscopy, Mutagenesis, Residue

Representation and validation of the AF4‐MALS‐FLD method . (A) Overview of the workflow used for identification of EV surface proteins. PE‐conjugated antibodies were incubated with the sample (e.g. pre‐purified EVs, cell culture supernatant, urine, or plasma) and loaded into the AF4 channel. (B) The light scatter elution profile (in relative scale) (black, full line), UV elution profile (black, dotted line) and the size determination ( R rms in nm) (red) obtained by the multi‐angle light scattering (MALS) detector is plotted against time for labelling of SK‐BR‐3‐derived EVs with PE‐conjugated anti‐CD81 antibody. (C) The fluorescent light detector (FLD) signal (in relative scale) for SK‐BR‐3‐derived EVs labelled with PE‐conjugated anti‐CD9, anti‐CD63 and anti‐CD81 is plotted against time. (D) Transmission electron microscopy (TEM) images of different fractions of the AF4‐MALS‐FLD elution profile are shown (scale bar = 200 nm).

Journal: Journal of Extracellular Biology

Article Title: A One‐Step Workflow for Size‐Based Separation of Extracellular Vesicles With Integrated Surface Marker Detection

doi: 10.1002/jex2.70109

Figure Lengend Snippet: Representation and validation of the AF4‐MALS‐FLD method . (A) Overview of the workflow used for identification of EV surface proteins. PE‐conjugated antibodies were incubated with the sample (e.g. pre‐purified EVs, cell culture supernatant, urine, or plasma) and loaded into the AF4 channel. (B) The light scatter elution profile (in relative scale) (black, full line), UV elution profile (black, dotted line) and the size determination ( R rms in nm) (red) obtained by the multi‐angle light scattering (MALS) detector is plotted against time for labelling of SK‐BR‐3‐derived EVs with PE‐conjugated anti‐CD81 antibody. (C) The fluorescent light detector (FLD) signal (in relative scale) for SK‐BR‐3‐derived EVs labelled with PE‐conjugated anti‐CD9, anti‐CD63 and anti‐CD81 is plotted against time. (D) Transmission electron microscopy (TEM) images of different fractions of the AF4‐MALS‐FLD elution profile are shown (scale bar = 200 nm).

Article Snippet: The following primary and secondary antibodies were used for western blot analysis: mouse monoclonal anti‐Alix (1:1000) (cat no. 2171S, Cell Signaling Technology), rabbit monoclonal anti‐CD9 (1:1000) (cat no. 13403S, Cell Signaling Technology), rabbit monoclonal anti‐Syntenin‐1 (1:1000) (cat no. ab133267, Abcam), mouse monoclonal anti‐TSG101 (1:1000) (cat no. sc‐7964, Santa Cruz Biotechnology), rabbit monoclonal anti‐PSMA (1:1000) (cat no. 12702S), mouse monoclonal anti‐EpCAM (1:1000) (cat no. 2929S, Cell Signaling Technology), rabbit monoclonal anti‐HER2 (1:1000) (cat no. 2165S, Cell Signaling Technology), mouse monoclonal anti‐GAPDH (1:2500) (cat no. G8795, Merck Life Science), sheep anti‐mouse horseradish peroxidase‐linked (1:3000) (cat no. NA931V, GE Healthcare Life Sciences) and donkey anti‐rabbit horseradish peroxidase‐linked antibody (1:8000) (cat no. NA934V, GE Healthcare Life Sciences).

Techniques: Biomarker Discovery, Incubation, Purification, Cell Culture, Clinical Proteomics, Multi-Angle Light Scattering, Derivative Assay, Transmission Assay, Electron Microscopy

AF4‐MALS‐FLD analysis of EV surface proteins with biomarker potential in prostate and breast cancer . MCF‐7‐, MDA‐MB‐231‐ and SK‐BR‐3‐derived EVs were labelled with PE‐conjugated anti‐EpCAM antibodies and analysed by AF4‐MALS‐FLD. (A) The elution profile (in relative scale) of the multi‐angle light scatter (MALS) detector and the size ( R rms in nm) were plotted against time. The fluorescent light detector (FLD) signal for MCF‐7‐, MDA‐MB‐231‐ and SK‐BR‐3‐derived EVs labelled with (B) PE‐conjugated anti‐EpCAM and (C) PE‐conjugated anti‐HER2 antibodies were plotted. (D) From FLD elution profiles, the area under the curve for the EV peak (24–80 min) was determined. Unstained EV samples were used as a negative control. (E) Different concentrations (6 × 10 9 , 8 × 10 9 , 1 × 10 10 and 2 × 10 10 particles as measured by NTA) including a negative control of LNCaP‐derived EVs (high PSMA expression) were labelled with anti‐PSMA antibodies and analysed by the AF4‐MALS‐FLD protocol. (F) The area under the curve for the EV peak was determined for LNCaP‐derived EVs. Different concentrations (2 × 10 10 , 4 × 10 10 and 6 × 10 10 particles as measured by NTA) including a negative control of (G) MCF‐7‐derived EVs (high EpCAM expression) or (I) SK‐BR‐3‐derived EVs (high HER2 expression) were labelled with PE‐conjugated anti‐EpCAM or anti‐HER2 antibodies respectively and analysed by the AF4‐MALS‐FLD protocol. The area under the curve for the EV peak (24–80 min) was determined for (H) MCF‐7‐ and (J) SK‐BR‐3‐derived EVs.

Journal: Journal of Extracellular Biology

Article Title: A One‐Step Workflow for Size‐Based Separation of Extracellular Vesicles With Integrated Surface Marker Detection

doi: 10.1002/jex2.70109

Figure Lengend Snippet: AF4‐MALS‐FLD analysis of EV surface proteins with biomarker potential in prostate and breast cancer . MCF‐7‐, MDA‐MB‐231‐ and SK‐BR‐3‐derived EVs were labelled with PE‐conjugated anti‐EpCAM antibodies and analysed by AF4‐MALS‐FLD. (A) The elution profile (in relative scale) of the multi‐angle light scatter (MALS) detector and the size ( R rms in nm) were plotted against time. The fluorescent light detector (FLD) signal for MCF‐7‐, MDA‐MB‐231‐ and SK‐BR‐3‐derived EVs labelled with (B) PE‐conjugated anti‐EpCAM and (C) PE‐conjugated anti‐HER2 antibodies were plotted. (D) From FLD elution profiles, the area under the curve for the EV peak (24–80 min) was determined. Unstained EV samples were used as a negative control. (E) Different concentrations (6 × 10 9 , 8 × 10 9 , 1 × 10 10 and 2 × 10 10 particles as measured by NTA) including a negative control of LNCaP‐derived EVs (high PSMA expression) were labelled with anti‐PSMA antibodies and analysed by the AF4‐MALS‐FLD protocol. (F) The area under the curve for the EV peak was determined for LNCaP‐derived EVs. Different concentrations (2 × 10 10 , 4 × 10 10 and 6 × 10 10 particles as measured by NTA) including a negative control of (G) MCF‐7‐derived EVs (high EpCAM expression) or (I) SK‐BR‐3‐derived EVs (high HER2 expression) were labelled with PE‐conjugated anti‐EpCAM or anti‐HER2 antibodies respectively and analysed by the AF4‐MALS‐FLD protocol. The area under the curve for the EV peak (24–80 min) was determined for (H) MCF‐7‐ and (J) SK‐BR‐3‐derived EVs.

Article Snippet: The following primary and secondary antibodies were used for western blot analysis: mouse monoclonal anti‐Alix (1:1000) (cat no. 2171S, Cell Signaling Technology), rabbit monoclonal anti‐CD9 (1:1000) (cat no. 13403S, Cell Signaling Technology), rabbit monoclonal anti‐Syntenin‐1 (1:1000) (cat no. ab133267, Abcam), mouse monoclonal anti‐TSG101 (1:1000) (cat no. sc‐7964, Santa Cruz Biotechnology), rabbit monoclonal anti‐PSMA (1:1000) (cat no. 12702S), mouse monoclonal anti‐EpCAM (1:1000) (cat no. 2929S, Cell Signaling Technology), rabbit monoclonal anti‐HER2 (1:1000) (cat no. 2165S, Cell Signaling Technology), mouse monoclonal anti‐GAPDH (1:2500) (cat no. G8795, Merck Life Science), sheep anti‐mouse horseradish peroxidase‐linked (1:3000) (cat no. NA931V, GE Healthcare Life Sciences) and donkey anti‐rabbit horseradish peroxidase‐linked antibody (1:8000) (cat no. NA934V, GE Healthcare Life Sciences).

Techniques: Biomarker Discovery, Derivative Assay, Multi-Angle Light Scattering, Negative Control, Expressing

Detection of EVs in complex matrices . (A) Different volumes of cell culture supernatant (0, 20, 40 and 60 µL) collected from the MCF‐7 cells were labelled with PE‐conjugated anti‐EpCAM antibodies and analysed by AF4‐MALS‐FLD. The area under the curve for the EV peak in complex matrices (40–80 min) was determined. (B) Different amounts of LNCaP‐derived EVs were spiked in 100 µL of concentrated urine, diluted 1:1 in PBS to reduce viscosity, labelled with PE‐conjugated anti‐PSMA antibodies, and analysed by AF4‐MALS‐FLD. The area under the curve for the EV peak was determined. Different amounts of (C) MCF‐7‐ or (D) SK‐BR‐3‐derived EVs were spiked in 100 µL of blood plasma, diluted 1:1 in PBS to reduce viscosity, and labelled with PE‐conjugated anti‐EpCAM or anti‐HER2 antibodies, respectively. Labelled EVs were analysed by AF4‐MALS‐FLD and the area under the curve for the EV peak was determined. Different amounts of SK‐BR‐3 EVs were also spiked in blood plasma and labelled with isotype control antibodies. (E) Different concentrations of soluble EpCAM (1, 5 and 10 ng/mL) and soluble HER2 (50, 100 and 150 ng/mL) were spiked in blood plasma, labelled with PE‐conjugated anti‐EpCAM or anti‐HER2 antibodies respectively, and analysed by AF4‐MALS‐FLD.

Journal: Journal of Extracellular Biology

Article Title: A One‐Step Workflow for Size‐Based Separation of Extracellular Vesicles With Integrated Surface Marker Detection

doi: 10.1002/jex2.70109

Figure Lengend Snippet: Detection of EVs in complex matrices . (A) Different volumes of cell culture supernatant (0, 20, 40 and 60 µL) collected from the MCF‐7 cells were labelled with PE‐conjugated anti‐EpCAM antibodies and analysed by AF4‐MALS‐FLD. The area under the curve for the EV peak in complex matrices (40–80 min) was determined. (B) Different amounts of LNCaP‐derived EVs were spiked in 100 µL of concentrated urine, diluted 1:1 in PBS to reduce viscosity, labelled with PE‐conjugated anti‐PSMA antibodies, and analysed by AF4‐MALS‐FLD. The area under the curve for the EV peak was determined. Different amounts of (C) MCF‐7‐ or (D) SK‐BR‐3‐derived EVs were spiked in 100 µL of blood plasma, diluted 1:1 in PBS to reduce viscosity, and labelled with PE‐conjugated anti‐EpCAM or anti‐HER2 antibodies, respectively. Labelled EVs were analysed by AF4‐MALS‐FLD and the area under the curve for the EV peak was determined. Different amounts of SK‐BR‐3 EVs were also spiked in blood plasma and labelled with isotype control antibodies. (E) Different concentrations of soluble EpCAM (1, 5 and 10 ng/mL) and soluble HER2 (50, 100 and 150 ng/mL) were spiked in blood plasma, labelled with PE‐conjugated anti‐EpCAM or anti‐HER2 antibodies respectively, and analysed by AF4‐MALS‐FLD.

Article Snippet: The following primary and secondary antibodies were used for western blot analysis: mouse monoclonal anti‐Alix (1:1000) (cat no. 2171S, Cell Signaling Technology), rabbit monoclonal anti‐CD9 (1:1000) (cat no. 13403S, Cell Signaling Technology), rabbit monoclonal anti‐Syntenin‐1 (1:1000) (cat no. ab133267, Abcam), mouse monoclonal anti‐TSG101 (1:1000) (cat no. sc‐7964, Santa Cruz Biotechnology), rabbit monoclonal anti‐PSMA (1:1000) (cat no. 12702S), mouse monoclonal anti‐EpCAM (1:1000) (cat no. 2929S, Cell Signaling Technology), rabbit monoclonal anti‐HER2 (1:1000) (cat no. 2165S, Cell Signaling Technology), mouse monoclonal anti‐GAPDH (1:2500) (cat no. G8795, Merck Life Science), sheep anti‐mouse horseradish peroxidase‐linked (1:3000) (cat no. NA931V, GE Healthcare Life Sciences) and donkey anti‐rabbit horseradish peroxidase‐linked antibody (1:8000) (cat no. NA934V, GE Healthcare Life Sciences).

Techniques: Cell Culture, Derivative Assay, Viscosity, Clinical Proteomics, Control

Validation of the AF4‐MALS‐FLD workflow on patient samples . Urine samples of five prostate cancer patients were labelled for PSMA and analysed by the AF4‐MALS‐FLD workflow. Fractions 40–80 min were collected, concentrated and processed for mass spectrometry‐based proteomic analysis. (A) EV markers Syntenin‐1, Flotillin‐1, CD63, CD9, CD81, Flotillin‐2, Alix and TSG101 were analysed (missing sample indicated in grey). Z ‐score transformation of intensities were plotted. (B) Targeted mass spectrometry analysed the presence of PSMA (FOLH1) in patient samples. The z ‐score transformation of intensities was plotted with the AF4‐MALS‐FLD peak area. (C) Blood plasma samples of healthy controls ( n = 7) and HER2 amplified breast cancer patients ( n = 10) were labelled with PE‐conjugated anti‐HER2 antibodies. (D) Blood plasma samples of healthy controls ( n = 6) and breast cancer patients ( n = 8) were labelled with PE‐conjugated anti‐EpCAM antibodies. The area under the curve values were normalised for the mean value in the healthy control group.

Journal: Journal of Extracellular Biology

Article Title: A One‐Step Workflow for Size‐Based Separation of Extracellular Vesicles With Integrated Surface Marker Detection

doi: 10.1002/jex2.70109

Figure Lengend Snippet: Validation of the AF4‐MALS‐FLD workflow on patient samples . Urine samples of five prostate cancer patients were labelled for PSMA and analysed by the AF4‐MALS‐FLD workflow. Fractions 40–80 min were collected, concentrated and processed for mass spectrometry‐based proteomic analysis. (A) EV markers Syntenin‐1, Flotillin‐1, CD63, CD9, CD81, Flotillin‐2, Alix and TSG101 were analysed (missing sample indicated in grey). Z ‐score transformation of intensities were plotted. (B) Targeted mass spectrometry analysed the presence of PSMA (FOLH1) in patient samples. The z ‐score transformation of intensities was plotted with the AF4‐MALS‐FLD peak area. (C) Blood plasma samples of healthy controls ( n = 7) and HER2 amplified breast cancer patients ( n = 10) were labelled with PE‐conjugated anti‐HER2 antibodies. (D) Blood plasma samples of healthy controls ( n = 6) and breast cancer patients ( n = 8) were labelled with PE‐conjugated anti‐EpCAM antibodies. The area under the curve values were normalised for the mean value in the healthy control group.

Article Snippet: The following primary and secondary antibodies were used for western blot analysis: mouse monoclonal anti‐Alix (1:1000) (cat no. 2171S, Cell Signaling Technology), rabbit monoclonal anti‐CD9 (1:1000) (cat no. 13403S, Cell Signaling Technology), rabbit monoclonal anti‐Syntenin‐1 (1:1000) (cat no. ab133267, Abcam), mouse monoclonal anti‐TSG101 (1:1000) (cat no. sc‐7964, Santa Cruz Biotechnology), rabbit monoclonal anti‐PSMA (1:1000) (cat no. 12702S), mouse monoclonal anti‐EpCAM (1:1000) (cat no. 2929S, Cell Signaling Technology), rabbit monoclonal anti‐HER2 (1:1000) (cat no. 2165S, Cell Signaling Technology), mouse monoclonal anti‐GAPDH (1:2500) (cat no. G8795, Merck Life Science), sheep anti‐mouse horseradish peroxidase‐linked (1:3000) (cat no. NA931V, GE Healthcare Life Sciences) and donkey anti‐rabbit horseradish peroxidase‐linked antibody (1:8000) (cat no. NA934V, GE Healthcare Life Sciences).

Techniques: Biomarker Discovery, Mass Spectrometry, Transformation Assay, Clinical Proteomics, Amplification, Control